circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis
Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal ce...
Saved in:
| Published in | Molecular cancer Vol. 20; no. 1; pp. 169 - 21 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
England
BioMed Central Ltd
18.12.2021
BioMed Central BMC |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC.
circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization.
The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression.
We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. |
|---|---|
| AbstractList | Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC. circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization. The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression. We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. Abstract Background Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC. Methods circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization. Results The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression. Conclusions We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC.BACKGROUNDCircular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC.circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization.METHODScircCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization.The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression.RESULTSThe expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression.We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC.CONCLUSIONSWe found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. Background Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC. Methods circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization. Results The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression. Conclusions We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. Keywords: hsa_circ_0020303, miR-125a-5p, EIF4EBP1, Proliferation, Metastasis, Clear cell renal cell carcinoma Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC. circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization. The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression. We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. Background Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA) sponges to regulate downstream gene expression. However, the aberrant expression profile and dysfunction of circRNAs in human clear cell renal cell carcinoma (ccRCC) need to be further investigated. This study mined key prognostic circRNAs and elucidates the potential role and molecular mechanism of circRNAs in regulating the proliferation and metastasis of ccRCC. Methods circCHST15 (hsa_circ_0020303) was identified by mining two circRNA microarrays from the Gene Expression Omnibus database and comparing matched tumor versus adjacent normal epithelial tissue pairs or matched primary versus metastatic tumor tissue pairs. These results were validated by quantitative real-time polymerase chain reaction and agarose gel electrophoresis. We demonstrated the biological effect of circCHST15 in ccRCC both in vitro and in vivo. To test the interaction between circCHST15 and miRNAs, we conducted a number of experiments, including RNA pull down assay, dual-luciferase reporter assay and fluorescence in situ hybridization. Results The expression of circCHST15 was higher in ccRCC tissues compared to healthy adjacent kidney tissue and higher in RCC cell lines compared to normal kidney cell lines. The level of circCHST15 was positively correlated with aggressive clinicopathological characteristics, and circCHST15 served as an independent prognostic indicator for overall survival and progression-free survival in patients with ccRCC after surgical resection. Our in vivo and in vitro data indicate that circCHST15 promotes the proliferation, migration, and invasion of ccRCC cells. Mechanistically, we found that circCHST15 directly interacts with miR-125a-5p and acts as a microRNA sponge to regulate EIF4EBP1 expression. Conclusions We found that sponging of miR-125a-5p to promote EIF4EBP1 expression is the underlying mechanism of hsa_circ_0020303-induced ccRCC progression. This prompts further investigation of circCHST15 as a potential prognostic biomarker and therapeutic target for ccRCC. |
| ArticleNumber | 169 |
| Audience | Academic |
| Author | Song, Hong-De Yao, Hao-Hua Li, Jia-Ying Liao, Bing Cao, Jia-Zheng Tang, Yi-Ming Yao, Gao-Sheng Wei, Jin-Huan Tan, Lei Gui, Cheng-Peng Lin, Hai-Shan Chen, Yu-Hang Xu, Quan-Hui Luo, Cheng-Gong Luo, Jun-Hang Xi-Liu Hou, Yi |
| Author_xml | – sequence: 1 givenname: Cheng-Peng surname: Gui fullname: Gui, Cheng-Peng – sequence: 2 givenname: Bing surname: Liao fullname: Liao, Bing – sequence: 3 givenname: Cheng-Gong surname: Luo fullname: Luo, Cheng-Gong – sequence: 4 givenname: Yu-Hang surname: Chen fullname: Chen, Yu-Hang – sequence: 5 givenname: Lei surname: Tan fullname: Tan, Lei – sequence: 6 givenname: Yi-Ming surname: Tang fullname: Tang, Yi-Ming – sequence: 7 givenname: Jia-Ying surname: Li fullname: Li, Jia-Ying – sequence: 8 givenname: Yi surname: Hou fullname: Hou, Yi – sequence: 9 givenname: Hong-De surname: Song fullname: Song, Hong-De – sequence: 10 givenname: Hai-Shan surname: Lin fullname: Lin, Hai-Shan – sequence: 11 givenname: Quan-Hui surname: Xu fullname: Xu, Quan-Hui – sequence: 12 givenname: Gao-Sheng surname: Yao fullname: Yao, Gao-Sheng – sequence: 13 givenname: Hao-Hua surname: Yao fullname: Yao, Hao-Hua – sequence: 14 surname: Xi-Liu fullname: Xi-Liu – sequence: 15 givenname: Jun-Hang surname: Luo fullname: Luo, Jun-Hang – sequence: 16 givenname: Jia-Zheng surname: Cao fullname: Cao, Jia-Zheng – sequence: 17 givenname: Jin-Huan surname: Wei fullname: Wei, Jin-Huan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34922539$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kt1u0zAcxSM0xD7gBbhAlrjhJps_E_sGaas6VmkSCMa19Y9jty5JXOx0g7fhUXHbDdYJoUSyY5_zs45zjouDIQy2KF4TfEqIrM4SoYqzElNSYsK5Ku-eFUeE11XJhZIHj-aHxXFKS4xJLWv-ojhkXFEqmDoqfhkfzeTqyw0RyCcEaAi3tkOrGOZDSKM3qPGhh_jNRjQuYNzs9GG0CZnOQkTGdh2KdoBuNzUQjR-yY_eZ1Z13NsLow4BgaFFvR0j5zYeNixjW80UeLer955JQAaVYnU1nl3x68Ykg-OHTy-K5gy7ZV_fjSfH1cnozuSqvP36YTc6vSyMqNpZEcacMBycYbZ0jppUKM8ExUYYy21AJzFaqblvHDa2cwZY5J7GghFkBip0Usx23DbDUq-hz6J86gNfbhRDnGmK-j85qCbLO5qbCSnJJGiDMyLppeFOBNXWTWe93rNW66W1r7DBG6Pag-zuDX-h5uNWykpxgmQHv7gExfF_bNOrep82FwmDDOmlaEYp5LTDO0rdPpMuwjvl_bFWE5YA1-auaQw7gBxfyuWYD1eeVYkJhLDes03-o8tPa3ptcPufz-p7hzeOgfxI-9CsL5E5gYkgpWqeNH7dlyGTfaYL1psp6V2Wdq6y3VdZ32UqfWB_o_zH9BkgO9lM |
| CitedBy_id | crossref_primary_10_18632_aging_205090 crossref_primary_10_1186_s12967_024_05290_9 crossref_primary_10_1016_j_trim_2022_101764 crossref_primary_10_3390_biom13010171 crossref_primary_10_1016_j_heliyon_2025_e42124 crossref_primary_10_1186_s12943_023_01766_2 crossref_primary_10_3389_fgene_2023_1173812 crossref_primary_10_1002_jcla_24670 crossref_primary_10_1016_j_cotox_2022_100348 crossref_primary_10_1016_j_trsl_2023_11_003 crossref_primary_10_1016_j_mcp_2022_101887 crossref_primary_10_1038_s41417_023_00684_1 crossref_primary_10_1016_j_envpol_2024_123395 crossref_primary_10_1007_s11255_024_04358_1 crossref_primary_10_1186_s12943_024_01940_0 crossref_primary_10_12677_ACM_2024_143790 crossref_primary_10_1515_biol_2022_0936 crossref_primary_10_1016_j_canlet_2023_216219 crossref_primary_10_3233_CBM_220145 crossref_primary_10_1080_15384101_2023_2274670 crossref_primary_10_1186_s12943_022_01607_8 crossref_primary_10_1002_ddr_22005 crossref_primary_10_1007_s12032_022_01669_0 crossref_primary_10_1186_s12935_023_03187_z crossref_primary_10_1186_s12882_024_03735_3 crossref_primary_10_3892_ol_2023_13782 crossref_primary_10_3390_biology12040493 crossref_primary_10_1186_s12935_023_03128_w crossref_primary_10_3389_fbioe_2022_948959 crossref_primary_10_1038_s41420_022_00948_z crossref_primary_10_1007_s13577_023_00877_8 crossref_primary_10_3389_fgene_2022_1046164 crossref_primary_10_1186_s12920_023_01687_5 |
| Cites_doi | 10.1016/j.jbiotec.2016.09.011 10.1038/s41467-018-06862-2 10.3322/caac.21654 10.1186/s13046-020-01648-1 10.1186/s12943-019-1060-9 10.1186/s13046-020-01679-8 10.7150/thno.19016 10.7554/eLife.05005 10.1038/nature11928 10.1186/s12943-020-01225-2 10.1371/journal.pone.0117493 10.1016/j.cell.2018.03.006 10.1186/s13046-019-1321-x 10.18632/oncotarget.6474 10.1200/JCO.2018.79.1905 10.1016/j.eururo.2015.10.017 10.1371/journal.pgen.1003777 10.1186/s13046-017-0624-z 10.1093/biostatistics/4.2.249 10.1186/s12943-018-0827-8 10.1016/j.gie.2017.10.030 10.1007/s11418-020-01435-4 10.1002/ijc.32319 10.1038/s41419-018-0454-8 10.1016/j.eururo.2016.06.009 10.1186/s12943-019-1072-5 10.1261/rna.035667.112 10.1016/j.canlet.2019.10.017 10.7150/thno.47239 10.1038/s41419-018-1287-1 10.1093/nar/gku1104 10.1038/nrm.2015.32 10.3892/or.2017.5354 10.1186/s12943-018-0908-8 10.1016/j.ygyno.2015.12.024 10.1038/nature11993 10.1111/cas.14261 |
| ContentType | Journal Article |
| Copyright | 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
| Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12943-021-01449-w |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1476-4598 |
| EndPage | 21 |
| ExternalDocumentID | oai_doaj_org_article_8a873ffb6098481ba13c87bb4b6aec7b PMC8684108 A693590080 34922539 10_1186_s12943_021_01449_w |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GroupedDBID | --- 0R~ 123 29M 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PZZ RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB CGR CUY CVF ECM EIF NPM PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
| ID | FETCH-LOGICAL-c563t-194f9c4af532dff1cd890354019c23eb28a3e697ddf4c26fc0e3ff805213e5a93 |
| IEDL.DBID | DOA |
| ISSN | 1476-4598 |
| IngestDate | Wed Aug 27 01:21:11 EDT 2025 Thu Aug 21 13:44:13 EDT 2025 Fri Jul 11 06:01:21 EDT 2025 Fri Jul 25 07:28:54 EDT 2025 Tue Jun 17 21:05:35 EDT 2025 Tue Jun 10 20:39:46 EDT 2025 Thu Apr 03 06:53:38 EDT 2025 Tue Jul 01 01:01:19 EDT 2025 Thu Apr 24 22:58:31 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | EIF4EBP1 hsa_circ_0020303 Clear cell renal cell carcinoma Metastasis Proliferation miR-125a-5p |
| Language | English |
| License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c563t-194f9c4af532dff1cd890354019c23eb28a3e697ddf4c26fc0e3ff805213e5a93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/8a873ffb6098481ba13c87bb4b6aec7b |
| PMID | 34922539 |
| PQID | 2611352171 |
| PQPubID | 42702 |
| PageCount | 21 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8a873ffb6098481ba13c87bb4b6aec7b pubmedcentral_primary_oai_pubmedcentral_nih_gov_8684108 proquest_miscellaneous_2612047500 proquest_journals_2611352171 gale_infotracmisc_A693590080 gale_infotracacademiconefile_A693590080 pubmed_primary_34922539 crossref_citationtrail_10_1186_s12943_021_01449_w crossref_primary_10_1186_s12943_021_01449_w |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-12-18 |
| PublicationDateYYYYMMDD | 2021-12-18 |
| PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-18 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Molecular cancer |
| PublicationTitleAlternate | Mol Cancer |
| PublicationYear | 2021 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | Z Liu (1449_CR12) 2019; 10 RL Siegel (1449_CR2) 2021; 71 Y Yao (1449_CR15) 2019; 38 J Salzman (1449_CR6) 2013; 9 DP Bartel (1449_CR38) 2018; 173 M Nishimura (1449_CR30) 2018; 87 LL Chen (1449_CR18) 2016; 17 M Lee (1449_CR25) 2016; 7 FR Kulcheski (1449_CR26) 2016; 238 YL Cha (1449_CR23) 2015; 10 H Liu (1449_CR28) 2018; 17 Z Chen (1449_CR8) 2020; 111 Y Zhang (1449_CR16) 2017; 36 J Li (1449_CR10) 2020; 19 W Gao (1449_CR24) 2017; 37 TB Hansen (1449_CR19) 2013; 495 T Powles (1449_CR4) 2016; 69 Y Matsuda (1449_CR31) 2019; 18 X Wang (1449_CR32) 2020; 43 Q Chen (1449_CR29) 2020; 469 1449_CR21 LC Liu (1449_CR33) 2019; 145 J Bi (1449_CR35) 2019; 18 Z Yang (1449_CR39) 2017; 7 1449_CR1 H Liu (1449_CR11) 2020; 10 SC van der Steen (1449_CR34) 2016; 140 WR Jeck (1449_CR7) 2013; 19 N Wong (1449_CR20) 2015; 43 S Memczak (1449_CR5) 2013; 495 W Hong (1449_CR9) 2020; 39 D Xue (1449_CR13) 2019; 18 Y Zhong (1449_CR36) 2018; 17 SQ Li (1449_CR22) 2020; 74 T Powles (1449_CR3) 2016; 70 RA Irizarry (1449_CR17) 2003; 4 K Zeng (1449_CR37) 2018; 9 M Zhang (1449_CR27) 2018; 9 Y Wang (1449_CR14) 2020; 39 |
| References_xml | – volume: 238 start-page: 42 year: 2016 ident: 1449_CR26 publication-title: J Biotechnol doi: 10.1016/j.jbiotec.2016.09.011 – volume: 9 start-page: 4475 year: 2018 ident: 1449_CR27 publication-title: Nat Commun doi: 10.1038/s41467-018-06862-2 – volume: 71 start-page: 7 year: 2021 ident: 1449_CR2 publication-title: CA Cancer J Clin doi: 10.3322/caac.21654 – volume: 39 start-page: 149 year: 2020 ident: 1449_CR9 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01648-1 – volume: 18 start-page: 133 year: 2019 ident: 1449_CR35 publication-title: Mol Cancer doi: 10.1186/s12943-019-1060-9 – volume: 39 start-page: 169 year: 2020 ident: 1449_CR14 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01679-8 – volume: 7 start-page: 3106 year: 2017 ident: 1449_CR39 publication-title: Theranostics doi: 10.7150/thno.19016 – ident: 1449_CR21 doi: 10.7554/eLife.05005 – volume: 495 start-page: 333 year: 2013 ident: 1449_CR5 publication-title: Nature doi: 10.1038/nature11928 – volume: 19 start-page: 103 year: 2020 ident: 1449_CR10 publication-title: Mol Cancer doi: 10.1186/s12943-020-01225-2 – volume: 10 year: 2015 ident: 1449_CR23 publication-title: PLoS One doi: 10.1371/journal.pone.0117493 – volume: 173 start-page: 20 year: 2018 ident: 1449_CR38 publication-title: Cell doi: 10.1016/j.cell.2018.03.006 – volume: 38 start-page: 318 year: 2019 ident: 1449_CR15 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1321-x – volume: 7 start-page: 8726 year: 2016 ident: 1449_CR25 publication-title: Oncotarget doi: 10.18632/oncotarget.6474 – ident: 1449_CR1 doi: 10.1200/JCO.2018.79.1905 – volume: 69 start-page: 4 year: 2016 ident: 1449_CR4 publication-title: Eur Urol doi: 10.1016/j.eururo.2015.10.017 – volume: 9 year: 2013 ident: 1449_CR6 publication-title: PLoS Genet doi: 10.1371/journal.pgen.1003777 – volume: 36 start-page: 152 year: 2017 ident: 1449_CR16 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-017-0624-z – volume: 43 start-page: 75 year: 2020 ident: 1449_CR32 publication-title: Oncol Rep – volume: 4 start-page: 249 year: 2003 ident: 1449_CR17 publication-title: Biostatistics doi: 10.1093/biostatistics/4.2.249 – volume: 17 start-page: 79 year: 2018 ident: 1449_CR36 publication-title: Mol Cancer doi: 10.1186/s12943-018-0827-8 – volume: 87 start-page: 1126 year: 2018 ident: 1449_CR30 publication-title: Gastrointest Endosc doi: 10.1016/j.gie.2017.10.030 – volume: 74 start-page: 777 year: 2020 ident: 1449_CR22 publication-title: J Nat Med doi: 10.1007/s11418-020-01435-4 – volume: 145 start-page: 2478 year: 2019 ident: 1449_CR33 publication-title: Int J Cancer doi: 10.1002/ijc.32319 – volume: 9 start-page: 417 year: 2018 ident: 1449_CR37 publication-title: Cell Death Dis doi: 10.1038/s41419-018-0454-8 – volume: 70 start-page: 705 year: 2016 ident: 1449_CR3 publication-title: Eur Urol doi: 10.1016/j.eururo.2016.06.009 – volume: 18 start-page: 151 year: 2019 ident: 1449_CR13 publication-title: Mol Cancer doi: 10.1186/s12943-019-1072-5 – volume: 19 start-page: 141 year: 2013 ident: 1449_CR7 publication-title: RNA doi: 10.1261/rna.035667.112 – volume: 469 start-page: 68 year: 2020 ident: 1449_CR29 publication-title: Cancer Lett doi: 10.1016/j.canlet.2019.10.017 – volume: 10 start-page: 10791 year: 2020 ident: 1449_CR11 publication-title: Theranostics doi: 10.7150/thno.47239 – volume: 10 start-page: 55 year: 2019 ident: 1449_CR12 publication-title: Cell Death Dis doi: 10.1038/s41419-018-1287-1 – volume: 43 start-page: D146 year: 2015 ident: 1449_CR20 publication-title: Nucleic Acids Res doi: 10.1093/nar/gku1104 – volume: 17 start-page: 205 year: 2016 ident: 1449_CR18 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2015.32 – volume: 37 start-page: 913 year: 2017 ident: 1449_CR24 publication-title: Oncol Rep doi: 10.3892/or.2017.5354 – volume: 17 start-page: 161 year: 2018 ident: 1449_CR28 publication-title: Mol Cancer doi: 10.1186/s12943-018-0908-8 – volume: 140 start-page: 527 year: 2016 ident: 1449_CR34 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2015.12.024 – volume: 495 start-page: 384 year: 2013 ident: 1449_CR19 publication-title: Nature doi: 10.1038/nature11993 – volume: 111 start-page: 713 year: 2020 ident: 1449_CR8 publication-title: Cancer Sci doi: 10.1111/cas.14261 – volume: 18 start-page: 4100 year: 2019 ident: 1449_CR31 publication-title: Oncol Lett |
| SSID | ssj0017874 |
| Score | 2.5057828 |
| Snippet | Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA (miRNA)... Background Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as microRNA... Abstract Background Circular RNAs (circRNAs) have been indicated as potentially critical mediators in various types of tumor progression, generally acting as... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 169 |
| SubjectTerms | Adaptor Proteins, Signal Transducing - genetics Adult Aged Animals Biomarkers Biomarkers, Tumor Breast cancer Carcinoma, Renal cell Carcinoma, Renal Cell - diagnosis Carcinoma, Renal Cell - genetics Cell culture Cell Cycle Proteins - genetics Cell growth Cell Line, Tumor Cell proliferation Clear cell renal cell carcinoma Clear cell-type renal cell carcinoma Development and progression Disease Models, Animal DNA microarrays EIF4EBP1 Female Fluorescence in situ hybridization Gel electrophoresis Gene expression Gene Expression Regulation, Neoplastic Genes Heterografts hsa_circ_0020303 Humans Kidney cancer Kidney Neoplasms - diagnosis Kidney Neoplasms - genetics Kidneys Male Medical prognosis Membrane Glycoproteins - genetics Metastases Metastasis Mice MicroRNA MicroRNAs - genetics Middle Aged Mineral industry Mining industry miR-125a-5p miRNA Models, Biological Neoplasm Grading Neoplasm Staging Patients Plasmids Polymerase chain reaction Prognosis Proliferation RNA Interference RNA, Circular Sulfotransferases - genetics Therapeutic targets Tumors Wound healing |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ta9QwGA86UfwiOt-qUyIIfpByzUvT5JNs445TmIhucN9CkibuYGtv127T_8Y_1Txt71wR9qkvSZqG5zXJk-eH0HvlQ7RSIUuzQtmUuyJEmTM0zVg0bkrQknUh_0dfxfyEf1nki2HBrRnCKjc6sVPUZe1gjXwSPX0SnQVSkE-rixRQo2B3dYDQuIvuQeoyCOkqFtsJF4nMyDcHZaSYNNG2cdi1hAk05yq9HhmjLmf__5r5hmkah03esEOzx-jR4EDi_Z7iT9AdX-2i-z2k5O9d9OBo2Cx_iv645dodzn8ckxwvG2xwVV_5MwwRWVUN6ZkxnL2H8Jw1bk9NCyWRcL7BDrAkMKzp47WH3rpbB7BDVWzRP64A7yf4noOwqUp87lsTnc0mdjbA_8Srx-fL72l0cEyarybTzzM-PfhGsPm1bJ6hk9n0-HCeDoAMqcsFa1OieFCOm5AzWoZAXClVBgtHRDnK4hxdGuaFKsoycEdFcJlnIXSgCcznRrHnaKeqK_8SYRakDKUlwTnCrTKmKFUohbNUeUYtSxDZUEa7IVs5gGac6W7WIoXuqakjNXVHTX2doI_bNqs-V8ettQ-A4NuakGe7e1Gvf-pBbLU0sohDsCJTgDtgDWFOFtZyK4x3hU3QB2AXDdog_p4zw6GGOEjIq6X3BZx8Brc8QXujmlGK3bh4w3B60CKN_sfzCXq3LYaWEBlX-fqyq0MzHv2--IkXPX9uhwSZJ2nOVIKKEeeOxjwuqZanXY5xKSQnmXx1-2-9Rg8piBOhKZF7aKddX_o30Ulr7dtOEv8CL-E7SA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELbGEIgXBONXYCAjIfGAwuLYcewHhLapVUEqQrBKe4scx94qdWlJMrb9N_yp3CVpWcTEE09Na7uJc_fl7uLzfYS80c6DlfJRGKU6D4VNPWDOxGHEwbhpGRe8TfmffpGTmfh8nBxvkTXdUX8D6xtDO-STmlWL95c_rj4C4D-0gFdyrwabJXA1EgNjIXR4cYvcBsuUIlCn4s-qAiinWG-cuXHcwDi1Nfz_flJfM1XDNMprdmn8gNzvHUq632nAQ7Llyh1yp6OYvNohd6f94vkj8svOK3s4-X7EEjqvqaHl8qdbUMzQKpdYrpniXnxM16loc2oabAFBuppa5Jag-I6fVg7P1h5apCEqYUT3dYX8P951GkVNWdAz1xhwPms4WU8HBJ-Ons2_heDwmDBZ7Y0-jcXo4Cuj5nJePyaz8ejocBL2BA2hTSRvQqaF11YYn_C48J7ZQukIXyQxbWMOMbsy3EmdFoUXNpbeRo5735IocJcYzZ-Q7XJZumeEcq-UL3LmrWUi18akhfaFtHmsHY9zHhC2lkxm--rlSKKxyNooRsmsk2YG0sxaaWYXAXm3GbPqanf8s_cBCnzTE-tutz8sq5Osh3GmjEphCrmMNPIQ5IZxq9I8F7k0zqZ5QN6iumSor3B51vSbHGCSWGcr25e4Exrd9IDsDnoCqu2wea1w2RoUGUS7DBxmUOyAvN4040jMlCvd8rztE0cC_ED4i6edfm6mhJUo44TrgKQDzR3MedhSzk_bmuNKKsEi9fx_3KQX5F6MoGNxyNQu2W6qc_cSXLsmf9Xi9TePUkw_ priority: 102 providerName: Scholars Portal |
| Title | circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34922539 https://www.proquest.com/docview/2611352171 https://www.proquest.com/docview/2612047500 https://pubmed.ncbi.nlm.nih.gov/PMC8684108 https://doaj.org/article/8a873ffb6098481ba13c87bb4b6aec7b |
| Volume | 20 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Rb9MwELZgCMQLggEjMCojIfGAosax49iP69SqIHWaxib1LbIdW6u0pVWbMfg3_FTukrRqhAQvvDRtbDdx7uy7i8_fR8hH7QNYqZDESa5tLFweYMyZNE44GDct05I3Kf-zMzm9El_n2XyP6gtzwlp44PbBDZVROQ_BykQj8rs1jDuVWyusNN7lFmdfsHnbYKpbPwA1FNstMkoON2DVBK5XYugshI7ve2aoQev_c07eM0r9hMk9CzR5Tp51riM9aW_5BXngq0PyuCWT_HlInsy6ZfKX5JdbrN3p9Nsly-hiQw2tlt_9DcVcrGqJwMwUd91jYs6a1temxhIQmd9QhywSFN_m07XHqzVfHRIOVdCi_blCpp_gW92hpirpra8NuJkbuFhH_ANHT28XFzG4NibOVsPxl4kYj84ZNT8Wm1fkajK-PJ3GHRVD7DLJ65hpEbQTJmQ8LUNgrlQ6wVdGTLuUQ3SuDPdS52UZhEtlcIkHoTV0CdxnRvPX5KBaVv4NoTwoFUrLgnNMWG1MXupQSmdT7XlqeUTYVjKF63DKkS7jpmjiFSWLVpoFSLNopFncR-Tzrs2qRen4a-0RCnxXExG2mxOgd0Wnd8W_9C4in1BdCpwH4Pac6bYzQCcRUas4kbjnGR3yiBz3asL4df3ircIV3fyxKSCuZeAas5xF5MOuGFtiTlzll3dNnTQR4PHBXxy1-rnrEmJOphnXEcl7mtvrc7-kWlw36OJKKsES9fZ_PKR35GmKg46lMVPH5KBe3_n34MTVdkAe5vN8QB6NxmfnF4Nm9MLnTKjfSJ9IHg |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLaqViwXBGUbKGAkEAcUNV6S2AeE2jLVlC6qSiv15jqOTUdqM8NkSum_4RfwG3kvyQyNkHrraRbbSaz3_Ja85SPknfYBtFSIozjTeSRdFuDMWR7FApSbTnkh6pT_3b10cCS_HifHC-TPrBYG0ypnMrEW1MXI4TvyVbD0GRgLLGOfxz8iRI3C6OoMQqNhi21_dQkuW_Vp6wvQ9z3nm_3DjUHUogpELknFNAKvPWgnbUgEL0JgrlA6xrcfTDsuwNFUVvhUZ0URpONpcLEXIdSd_4VPLDZfApG_JAW4Motkab2_t38wj1sA-8tZaY5KVyvQphLjpOiyS6mjy476q1EC_tcF15RhN1HzmubbfEgetCYrXWt47BFZ8OUyudOAWF4tk7u7bXj-MfnthhO3Mfh2yBI6rKil5einP6OYA1aOsCE0xWp_TAia0OmpneIIsIqvqEP0CopRBDrxeLf6q0OgoxJWND_HiDAUfMOz1JYFPfdTC-ZtBTdrAYfg09Pz4UEEJpWNkvFqf2tT9tf3GbW_htUTcnQrxHpKFstR6Z8TKoJSochZcI7JXFubFToUqcu59oLnokfYjDLGtf3REabjzNR-kkpNQ00D1DQ1Nc1lj3ycrxk33UFunL2OBJ_PxM7e9R-jyXfTCgqjrMpgC3kaa0Q6yC0TTmV5LvPUepflPfIB2cWg_IHHc7Yto4BNYicvs5ZirTU6Aj2y0pkJcsN1h2cMZ1q5VZl_p6xH3s6HcSXm4pV-dFHP4bEESxMu8azhz_mWsNclT4TukazDuZ09d0fK4Wnd1VylSrJYvbj5sd6Qe4PD3R2zs7W3_ZLc53i0GI-YWiGL08mFfwUm4jR_3Z5LSk5uWxT8BXgBecE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=circCHST15+is+a+novel+prognostic+biomarker+that+promotes+clear+cell+renal+cell+carcinoma+cell+proliferation+and+metastasis+through+the+miR-125a-5p%2FEIF4EBP1+axis&rft.jtitle=Molecular+cancer&rft.au=Cheng-Peng+Gui&rft.au=Bing+Liao&rft.au=Cheng-Gong+Luo&rft.au=Yu-Hang+Chen&rft.date=2021-12-18&rft.pub=BMC&rft.eissn=1476-4598&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=21&rft_id=info:doi/10.1186%2Fs12943-021-01449-w&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8a873ffb6098481ba13c87bb4b6aec7b |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon |